DIA, the Drug Information Association, has set up an office in Mumbai, India, reported PJB news.
Subscribe to our email newsletter
According to the DIA, the biopharmaceutical industry in India will be worth $1 billion by 2010, up from $60 million in 2003 and $100 million in 2006. The DIA intends to capitalize on the industry’s rapid growth in the country and has also established a provisional Advisory Council of India to help plan its initiatives in the country.
Linda McGoldrick, DIA’s worldwide executive director, predicts that by 2011, India will account for 15% share in the global clinical trials market.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.